To gain insight into the clinical importance of our cell line data, we determined sPD-L1 and HGF serum levels in HNSCC patients before they were treated with different ICIs specific for the PD1/PD-L1 checkpoint. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.